Zhang J, et al. - This study was undertaken to investigate the efficacy and safety of 1470-nm Diode Laser Enucleation of the Prostate (DiLEP) in individuals with benign prostatic hyperplasia continuously receiving oral anticoagulants or antiplatelet drugs. A total of 144 individuals were submitted to 1470-nm DiLEP, including 49 (34.0%) continuously administered anticoagulants or antiplatelet drugs per os due to cardiac and/or cerebrovascular diseases (group A), while 95 (66.0%) were not (group B) between January 2016 and June 2017. They analyzed individual baseline features, operative data, perioperative complications, and postsurgical outcomes. The 1470-nm DiLEP was found to be safe and effective in benign prostatic hyperplasia cases receiving continuous oral anticoagulant or antiplatelet drugs. It was noted that anticoagulation therapy did not significantly affect outcomes and complication rates.